A CASE OF SPORADIC KARYOMEGALIC INTERSTITIAL NEPHRITIS WITH A NOVEL FAN1 GENE MUTATION: THE FIRST REPORT IN EAST ASIA.

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/4af2d48bdf1dde62b91f795bcafc7994.pdf
A CASE OF SPORADIC KARYOMEGALIC INTERSTITIAL NEPHRITIS WITH A NOVEL FAN1 GENE MUTATION: THE FIRST REPORT IN EAST ASIA.

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Maria
Yoshida
Maria Yoshida mariayoshida@hiroshima-u.ac.jp Hiroshima University Hospital Nephrology Hiroshima Japan *
Yujiro Maeoka ymaeoka@hiroshima-u.ac.jp Hiroshima University Hospital Nephrology Hiroshima Japan -
Yasunao Kamikawa kamikawa@hiroshima-u.ac.jp Institute of Biomedical & Health Sciences, Hiroshima University Biochemistry Hiroshima Japan -
Takeshi Ike tike2@hiroshima-u.ac.jp Hiroshima University Hospital Nephrology Hiroshima Japan -
Kazunori Imaizumi imaizumi@hiroshima-u.ac.jp The Osaka medical research foundation for intractable diseases Biochemistry Osaka Japan - Japan and Department of Child Development and Molecular Brain Science United Graduate School of Child Development Osaka Japan
Toshinori Ueno tueno0801@gmail.com Hiroshima Prefectural Hospital Nephrology Hiroshima Japan -
Takashi Nishisaka tnishisaka@hiroshima.hpho.jp Hiroshima Prefectural Hospital Pathology Hiroshima Japan -
Takayuki Naito t-naito@icy.or.jp Ichiyokai Yokogawa Clinic Nephrology Hiroshima Japan -
Michio Nagata nagatam1207@gmail.com Itabashi Chuo Medical Center Diagnostic Pathology Tokyo Japan -
Kandai Nozu nozu@med.kobe-u.ac.jp Kobe University Graduate School of Medicine Pediatrics Kobe Japan -
Takayasu Mori tmori.kid@tmd.ac.jp Graduate School of Medical and Dental Sciences, Institute of Science Tokyo Nephrology Tokyo Japan -
Eisei Sohara esohara.kid@tmd.ac.jp Graduate School of Medical and Dental Sciences, Institute of Science Tokyo Nephrology Tokyo Japan -
Shinichi Uchida suchida.kid@tmd.ac.jp Graduate School of Medical and Dental Sciences, Institute of Science Tokyo Nephrology Tokyo Japan -
Takao Masaki masakit@hiroshima-u.ac.jp Hiroshima University Hospital Nephrology Hiroshima Japan -
-